sFlt-1 – Medxy AI

Anti-Angiogenic Profile at Term Signals Faster Labour Onset in Low-Risk Pregnancies, Study Finds

By MedXY 04/02/2026

Prospective cohort data from Switzerland reveal that elevated sFlt-1/PlGF ratios at term correlate with shorter time to spontaneous delivery in low-risk pregnancies, while PlGF declines and sFlt-1 rises from term to post-term. These findings suggest angiogenic biomarkers may help refine late-term risk stratification.

Cardiology news OB/GYN & Women's Health

Pregnancy as a Window to Longevity: Maternal Biomarkers at 29 Weeks Predict Long-Term Cardiovascular Risk

By MedXY 02/20/2026

A Danish cohort study demonstrates that specific pregnancy biomarkers, particularly sFlt-1 and hs-cTnI measured at 29 weeks, significantly enhance the prediction of long-term cardiovascular disease risk in women, independent of traditional clinical factors and hypertensive disorders of pregnancy.